The global biotechnology market stands poised to reach an unprecedented $5.85 trillion by 2034. The compound annual growth of 13.6% from its current $1.64 trillion valuation tells only part of the story.
Beneath these staggering projections lies a fundamental challenge that could determine which companies thrive during this expansion: the acute shortage of mission-aligned talent capable of executing on biotechnology’s transformative promise.
Examining how entrepreneurs have navigated similar high-growth markets
